TETRAPHASE PHARMACEUTICALS INC: capex

Value{"amount": 106000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2019-01-01 – 2019-06-30
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-030922 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/capex/2019-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b6a7d93f-84a7-4abe-abb9-ffe0bd28e97a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies